Flow Cytometric Analysis of Circulating Microparticles in Plasma

被引:263
|
作者
Orozco, Aaron F. [1 ]
Lewis, Dorothy E. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA
关键词
quantitation of plasma microparticles; polychromatic flow cytometric analysis; Western blotting polyclonal antibodies; II TYPE-1 RECEPTOR; BREAST-CANCER PATIENTS; ENDOTHELIAL MICROPARTICLES; APOPTOTIC BODIES; NUCLEIC-ACIDS; IN-VITRO; T-CELLS; ACTIVATION; VESICLES; PLATELET;
D O I
10.1002/cyto.a.20886
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Microparticles, which include exosomes, micro-vesicles, apoptotic bodies and apoptotic microparticles, are small (0.05 - 3 mu m in diameter), membranous vesicles that can contain DNA, RNA, miRNA, intracellular proteins and express extracellular surface markers from the parental cells. They can be secreted from intracellular multivesicular bodies or released from the surface of blebbing membranes. Circulating microparticles are abundant in the plasma of normal individuals and can be derived from circulating blood cells such as platelets, red blood cells and leukocytes as well as from tissue sources, such as endothelial and placental tissues. Elevated levels of microparticles are associated with various diseases such as thrombosis (platelet microparticles), congestive heart failure (endothelial microparticles), breast cancer patients (leukocyte microparticles) and women with preeclampsia (syncytiotrophoblast microparticles). Although microparticles can be detected by microscopy, enzyme-linked immunoassays and functional assays, flow cytometry is the preferred method because of the ability to quantitate (fluorescent bead- or flow rate-based method) and because of polychromatic capabilities. However, standardization of pre-analytical and analytical modus operandi for isolating, enumerating and fluorescent labeling of microparticles remains a challenge. The primary focus of this article is to review the preliminary steps required to optimally study circulating in vivo microparticles which include: 1) centrifugation speed used, 2) quantitation of microparticles before antibody labeling, 3) levels of fluorescence intensity of antibody-labeled microparticles, 4) polychromatic flow cytometric analysis of microparticle sub-populations and 5) use of polyclonal antibodies designed for Western blotting for flow cytometry. These studies determine a roadmap to develop microparticles as biomarkers for a variety of conditions. (C) 2010 International Society for Advancement of Cytometry
引用
收藏
页码:502 / 514
页数:13
相关论文
共 50 条
  • [1] Flow cytometric assessment of circulating microparticles - towards a more objective analysis
    Huica, R.
    Huica, S.
    Moldoveanu, E.
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2011, 16 (03): : 6271 - 6277
  • [2] Circulating microparticles: challenges and perspectives of flow cytometric assessment
    Shantsila, Eduard
    Montoro-Garcia, Silvia
    Gallego, Pilar
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (06) : 1009 - 1014
  • [3] Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysis
    Kong, Fancong
    Zhang, Liming
    Wang, Hongxiang
    Yuan, Guolin
    Guo, Anyuan
    Li, Qiubai
    Chen, Zhichao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (06) : 2093 - 2101
  • [4] Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis
    Bhagwat, Neha
    Carpenter, Erica L.
    ISOLATION AND MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS, 2017, 994 : 105 - 118
  • [5] Correlative analysis of nanoparticle tracking, flow cytometric and functional measurements for circulating microvesicles in normal subjects
    Enjeti, Anoop K.
    Ariyarajah, Anita
    D'Crus, Angel
    Seldon, Michael
    Lincz, Lisa F.
    THROMBOSIS RESEARCH, 2016, 145 : 18 - 23
  • [6] A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: Relevance for the evaluation of endothelial dysfunction
    Lanuti, Paola
    Santilli, Francesca
    Marchisio, Marco
    Pierdomenico, Laura
    Vitacolonna, Ester
    Santavenere, Eugenio
    Lacone, Antonio
    Davi, Giovanni
    Romano, Mario
    Miscia, Sebastiano
    JOURNAL OF IMMUNOLOGICAL METHODS, 2012, 380 (1-2) : 16 - 22
  • [7] Circulating microparticles and risk of venous thromboembolism
    Bucciarelli, Paolo
    Martinelli, Ida
    Artoni, Andrea
    Passamonti, Serena M.
    Previtali, Emanuele
    Merati, Giuliana
    Tripodi, Armando
    Mannucci, Pier Mannuccio
    THROMBOSIS RESEARCH, 2012, 129 (05) : 591 - 597
  • [8] A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer
    Iversen, Line V.
    Ostergaard, Ole
    Nielsen, Christoffer T.
    Jacobsen, Soren
    Heegaard, Niels H. H.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2013, 388 (1-2) : 49 - 59
  • [9] Validation of flow cytometric detection of platelet microparticles and liposomes by atomic force microscopy
    Leong, H. S.
    Podor, T. J.
    Manocha, B.
    Lewis, J. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (12) : 2466 - 2476
  • [10] Circulating CD62E+ Microparticles and Cardiovascular Outcomes
    Lee, Soon-Tae
    Chu, Kon
    Jung, Keun-Hwa
    Kim, Jeong-Min
    Moon, Hye-Jin
    Bahn, Jae-Jun
    Im, Woo-Seok
    Sunwoo, Junsang
    Moon, Jangsup
    Kim, Manho
    Lee, Sang Kun
    Roh, Jae-Kyu
    PLOS ONE, 2012, 7 (04):